Intrance Medical Systems logo
Startup

Intrance Medical Systems

See Intrance Medical Systems's full profile

BOOK A DEMO
Headquarters

Sweden

Founded Year

2018

Total Funding

$8.0M

Employees Status

Active


About Intrance Medical Systems

Intrance Medical Systems is a private biopharmaceutical company focused on the development and commercialization of its lead clinical product for the treatment of advanced Parkinson’s disease in the U.S. Canada, South America, Japan and Taiwan.

Headquarters

Sweden


General Information on Intrance Medical Systems

Brand name Intrance Medical Systems
Company name Intrance Holdings AB
Website https://www.intrancemedical.com/
Founded year 2018
Employees None
Founding team

Patrick Shea

Contact [email protected]

Find startup solutions in your specific business context

The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.
BOOK A DEMO

Recent News and Activity about Intrance Medical Systems

Register-Herald, The (Beckley, WV) 04.01.2022
Intrance Medical Systems Completes $17 Million Series A Financing and Appoints Ed Schutter to Board of Directors

STOCKHOLM NEW YORK--(BUSINESS WIRE)--Jan 4, 2022-- Intrance Medical Systems Inc., a subsidiary of Sweden-based Intrance Holdings AB, today announced that it has completed the final round of a Series A financing, totaling USD $17 million. Internationally well renowned Scandinavian investors, Erik Selin and Rutger Arnhult, participated in the financing as anchor investors. Proceeds from the financing will enable Intrance to initiate pivotal U.S. ...

The Galveston County Daily News 20.09.2021
Intrance Medical Systems Raises $8 Million to Support Development of Its Innovative Therapy for Advanced Parkinson's Disease

Intrance Medical Systems Inc., a subsidiary of Sweden-based Intrance Holdings AB, today announced the company has secured USD $8 million from prominent Swedish real estate investor Erik Selin through his private company, Erik Selin Fastigheter AB. Mr. Selin has agreed to become the anchor investor as part of a Series A financing round of USD $15 million, becoming the largest shareholder next to the founders. Funding will be used to initiate the ...

Intrance Medical Systems news
Finsmes 20.09.2021
Intrance Medical Systems Raises $8M in Series A Funding

Swedish real estate investor Erik Selin made the investement through his private company, Erik Selin Fastigheter AB. Mr. Selin has agreed to become the anchor investor as part of a Series A financing round of USD $15m, becoming the largest shareholder next to the founders.Funding will be used to initiate the U.S. clinical development program for its fixed-dose combination treatment of carbidopa, entacapone and levodopa for enteral infusion in ...

azcentral.com (Arizona) 20.09.2021
Intrance Medical Systems Raises $8 Million to Support Development of Its Innovative Therapy for Advanced Parkinson’s Disease | Help Center - The Arizona Republic

Intrance Medical Systems Inc., a subsidiary of Sweden-based Intrance Holdings AB, today announced the company has secured USD $8 million from

Nordic Life Science 20.09.2021
Intrance Medical Systems raises 8 million USD

Erik Selin has agreed to become the anchor investor as part of a Series A financing round of 15 million USD, becoming the largest shareholder next to the founders.“I was intrigued by the founder’s story, their achievements as entrepreneurs and how their innovative drug-device treatment can have a significant and positive impact on people living with this progressive and chronic condition,” says Erik Selin. “In addition, with an experienced team ...

Intrance Medical Systems news
StreetInsider 18.08.2021
Intrance Medical Systems Names Krai Chatamra, Ph.D., Vice President of Clinical Development

neurodegenerative disorders, including advanced Parkinson's disease, that will be invaluable to our company,” said Patrick Shea, Chief Executive Officer of Intrance Medical Systems. “His deep knowledge and clinical leadership will be instrumental as we advance our lead asset, a next-generation, device-assisted therapy that has the potential to become a new standard of care for patients with advanced Parkinson's disease.” In his role at Intrance, ...

Intrance Medical Systems news